Navigation Links
American Chemical Society's Weekly PressPac -- Sept. 10, 2008
Date:9/15/2008

>http://dx.doi.org/10.1021/nl800925j

CONTACT:
Gaoping Cao, Ph.D.
Research Institute of Chemical Defense
Beijing, China
Phone: 86-10-66705840
Fax: 86-10-66748574
Email: mailto:etwas-chang@sohu.com


ARTICLE #5 EMBARGOED FOR 9 A.M., EASTERN TIME, Sept. 15, 2008

New medications for schizophrenia
Chemical & Engineering News

New scientific insights into schizophrenia are pointing toward new drugs that offer hope for millions of individuals with the disease the most serious form of mental illness, according to an article scheduled for the Sept. 15 issue of Chemical & Engineering News, ACS' weekly newsmagazine. Schizophrenia affects about 25 million people, or about one percent of adults, worldwide.

In the article, C&EN Assistant Editor Carmen Drahl notes that existing medications for schizophrenia, so-called antipsychotics, help ease some symptoms, such as hallucinations and disorganized speech. However, they do not deal with all of the disease's symptoms, such as lack of motivation and impairments to decision-making.

Researchers are now moving beyond traditional drugs, which generally target dopamine neurotransmission, and focusing on new targets that might tackle a wider range of symptoms. The article describes animal and human trials of several potential new drugs that focus on new disease targets, including the glutamate neurotransmitter system, a nicotinic acetylcholine receptor, and a signaling pathway mediated by cyclic nucleotides.

These substances appear to help relieve a wider range of symptoms while causing fewer side effects, the researchers note. "We're still trying to understand the basic mechanisms of schizophrenia, which will hopefully lead to more effective treatments that target core features of the illness," notes an outside expert.

ARTICLE #5 EMBARGOED FOR 9 A.M., E
'/>"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
Source:Eurekalert  

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. New gene variant identified for nondiabetic end stage renal disease in African-Americans
2. Silent streams? Escalating endangerment for North American freshwater fish
3. American Chemical Societys Weekly PressPac -- Sept. 3, 2008
4. African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease
5. NYU, American Museum of Natural History receive $1.6 million NSF grant
6. American Chemical Societys Weekly PressPac -- Aug. 27, 2008
7. Highlights from the September 2008 Journal of the American Dietetic Association
8. Gene therapy anti-cancer research featured in Scientific American
9. American Chemical Societys Weekly PressPac -- Aug. 13, 2008
10. American Chemical Societys Weekly PressPac -- Aug. 6, 2008
11. Study helps pinpoint genetic variations in European Americans
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
American Chemical Society's Weekly PressPac -- Sept. 10, 2008
(Date:6/29/2015)... DUBLIN , June 24, 2015 ... the addition of the "Latin America Biomedical Sensors ... to their offering. The Latin America Biomedical ... at a CAGR of 2.04% over the period 2014-2020 ... that are adaptable to the genetic formulation of each ...
(Date:6/25/2015)... , June 25, 2015 ... Market by Type (Swipe & Area), Technology, Material (Optical ... Healthcare, Commercial Security & Others) & Geography - ... marketsandmarkets, the said market is expected to reach ... 17.1%. Browse 76 market Tables ...
(Date:6/25/2015)... -- TAKE Solutions Ltd., a global business technology solutions provider, ... and Trademark Office (USPTO) for its "Method for Optimizing ... Accelerators to reduce the time taken to standardize trial ... the accelerators), thus reducing time to market. ... heart of the patented Clinical Data Standardization Process are ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4TAKE Solutions Awarded Patent By USPTO 2
... Applied scientists demonstrated a new method for developing wrinkled ... a focused ion beam. By controlling the direction and ... patterns on flat areas of polydimethylsiloxane, a silicon-based organic ... Silly Putty). The technique has potential use for biological ...
... antiviral drugs, oseltamivir and zanamivir, are highly effective ... the spread of the influenza virus, according to ... Fred Hutchinson Cancer Research Center, University of Michigan ... print edition of the American Journal of Epidemiology. ...
... power of the sun could be available for the treatment of ... be seen whether the drug will be the revolution in prostate ... (DN-101), is based on vitamin D and is given to patients ... Drug makers came up with the idea because vitamin D ...
Cached Biology News:Applied scientists create wrinkled 'skin' on polymers 2Antivirals effectively curb influenza virus 2Antivirals effectively curb influenza virus 3Sunshine pill for prostate cancer in 2009 2
(Date:7/2/2015)... ... 2015 , ... In’Tech Medical SAS ( http://www.intech-medical.com ), a ... the acquisition of Turner Medical, Inc ., thus becoming a global leader ... Spine Industry. The acquisition of Turner Medical ideally supplements In’Tech Medical’s product offering, ...
(Date:7/1/2015)... ... July 01, 2015 , ... The next-generation sequencing (NGS) clinical market is ... the molecular diagnostics industry. BCC Research reveals in its new report that the market ... costs, and a growing need for better diagnostics as part of a molecular diagnostics ...
(Date:7/1/2015)... , July 1, 2015 Isagenix International, ... has earned three Gold, three Silver, and three Bronze ... gala held in Chicago this ... the premier business awards program in the U.S. ... our company,s strength in developing leaders, cultivating talent, creating ...
(Date:7/1/2015)... ... July 01, 2015 , ... NEMA 4 (IP66) Medical ... new Medical Joysticks have an impermeable molecular barrier protection against bio-hazardous agents. ... that will increase healthcare worker safety and reduce financial costs. , CTI Electronics ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2
...  MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, ... and bioimplants processed from human amniotic membrane, announced ... to sell convertible notes and warrants has been ... commenced on October 15, 2011, the Company received ...
... Dec. 27, 2011  While many Americans are resolving to address ... shows that some adults are looking to find answers to ... The survey, which was commissioned by Identigene, the ... Identigene DNA Paternity Test, the only paternity test available at ...
... 27, 2011 Cord Blood America, Inc . ( ... umbilical cord blood stem cell preservation company focused ... families nationwide and internationally, is pleased to announce it has ... Las Vegas laboratory for the National Children,s Leukemia Foundation (NCLF), ...
Cached Biology Technology:MiMedx Group Completes $5,000,000 Private Placement 2MiMedx Group Completes $5,000,000 Private Placement 3Survey Reveals Paternity Questions Loom for More Than One in 10 Americans 2Survey Reveals Paternity Questions Loom for More Than One in 10 Americans 3Cord Blood America Announces Exclusive Agreement With National Children's Leukemia Foundation to Store Stem Cells 2
Each bottle contains: Bromophenol Blue 0.25% w/v , Xylene Cyanol FF 0.25%, Glycerol solution 30% w/v...
Ideally suited for resolving DNA and RNA 10-1000 bases especially PCR products ranging from 100-1000 bp. Gelling temp. (4%) 27C Melting temperature 65C. EEO: 0.10 Rnase/Dnase: none detected...
XEDAR Antibody...
Xanthine Oxidase (Bovine Buttermilk). Monospecific by IEP. Some cross reactivity with Xanthine Oxidase of other species and tissues may occur....
Biology Products: